Nasal Methicillin Resistant Staphylococcus Aureus Colonisation and the Incidence of Invasive Staphylococcal Infection in Patients Undergoing Hemodialysis
- PMID: 40352893
- PMCID: PMC12065608
- DOI: 10.25259/IJN_418_2024
Nasal Methicillin Resistant Staphylococcus Aureus Colonisation and the Incidence of Invasive Staphylococcal Infection in Patients Undergoing Hemodialysis
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Methicillin-resistant Staphylococcus aureus: Prevalence, incidence, risk factors, and effects on survival of patients in a specialist palliative care unit: A prospective observational study.Palliat Med. 2016 Apr;30(4):374-81. doi: 10.1177/0269216315595158. Epub 2015 Jul 31. Palliat Med. 2016. PMID: 26231420
-
Meticillin-resistant Staphylococcus aureus in a veterinary orthopaedic referral hospital: staff nasal colonisation and incidence of clinical cases.J Small Anim Pract. 2008 Apr;49(4):170-7. doi: 10.1111/j.1748-5827.2007.00529.x. J Small Anim Pract. 2008. PMID: 18339087
-
Pre-surgical Nasal Decolonization of Staphylococcus aureus: A Health Technology Assessment.Ont Health Technol Assess Ser. 2022 Aug 23;22(4):1-165. eCollection 2022. Ont Health Technol Assess Ser. 2022. PMID: 36160757 Free PMC article. Review.
-
Spa gene-based molecular typing of nasal methicillin-susceptible staphylococcus aureus from patients and health-care workers in a dialysis center in southeast Iran.Pathog Glob Health. 2020 May;114(3):160-163. doi: 10.1080/20477724.2020.1743933. Epub 2020 Mar 26. Pathog Glob Health. 2020. PMID: 32212921 Free PMC article.
-
The epidemiology of methicillin-resistant Staphylococcus aureus colonisation and infection.J Chemother. 1995 Jul;7 Suppl 3:99-103. J Chemother. 1995. PMID: 8609545 Review.
References
-
- CLSI . Performance standards for antimicrobial susceptibility testing. 30th ed. Clinical and Laboratory Standards Institute; 2023. CLSI document M100.
-
- U.S. Centers for Disease Control and Prevention . The National Healthcare Safety Network (NHSN) Manual: NHSN [2022] Toolkit and Guidance for External Validation. Atlanta, GA: Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases; https://www.cdc.gov/nhsn/pdfs/validation/2022/2022-nhsn-ev-guidance-508.pdf .
-
- Bassetti M, Del Puente F, Magnasco L, Giacobbe DR. Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: Advances in phase I and II trials. Expert Opin Investig Drugs. 2020;29:495–506. doi: 10.1080/13543784.2020.1750595. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources